JPWO2021035177A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021035177A5
JPWO2021035177A5 JP2022511274A JP2022511274A JPWO2021035177A5 JP WO2021035177 A5 JPWO2021035177 A5 JP WO2021035177A5 JP 2022511274 A JP2022511274 A JP 2022511274A JP 2022511274 A JP2022511274 A JP 2022511274A JP WO2021035177 A5 JPWO2021035177 A5 JP WO2021035177A5
Authority
JP
Japan
Prior art keywords
variant
domain monomer
domain
amino acid
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022511274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545106A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/047490 external-priority patent/WO2021035177A2/fr
Publication of JP2022545106A publication Critical patent/JP2022545106A/ja
Publication of JPWO2021035177A5 publication Critical patent/JPWO2021035177A5/ja
Pending legal-status Critical Current

Links

JP2022511274A 2019-08-22 2020-08-21 バリアントfcドメイン及びその使用 Pending JP2022545106A (ja)

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
US201962890475P 2019-08-22 2019-08-22
US62/890,475 2019-08-22
US201962897036P 2019-09-06 2019-09-06
US62/897,036 2019-09-06
US201962941405P 2019-11-27 2019-11-27
US62/941,405 2019-11-27
US201962948143P 2019-12-13 2019-12-13
US62/948,143 2019-12-13
US202062959857P 2020-01-10 2020-01-10
US62/959,857 2020-01-10
US202062966500P 2020-01-27 2020-01-27
US62/966,500 2020-01-27
US202062970491P 2020-02-05 2020-02-05
US62/970,491 2020-02-05
US202062984705P 2020-03-03 2020-03-03
US62/984,705 2020-03-03
US202062988304P 2020-03-11 2020-03-11
US62/988,304 2020-03-11
US202062988821P 2020-03-12 2020-03-12
US62/988,821 2020-03-12
US202063032488P 2020-05-29 2020-05-29
US202063032316P 2020-05-29 2020-05-29
US63/032,488 2020-05-29
US63/032,316 2020-05-29
US202063062377P 2020-08-06 2020-08-06
US63/062,377 2020-08-06
PCT/US2020/047490 WO2021035177A2 (fr) 2019-08-22 2020-08-21 Domaines fc variants et leurs utilisations

Publications (2)

Publication Number Publication Date
JP2022545106A JP2022545106A (ja) 2022-10-25
JPWO2021035177A5 true JPWO2021035177A5 (fr) 2023-08-28

Family

ID=74660747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022511274A Pending JP2022545106A (ja) 2019-08-22 2020-08-21 バリアントfcドメイン及びその使用

Country Status (9)

Country Link
US (1) US20220175943A1 (fr)
EP (1) EP4017529A4 (fr)
JP (1) JP2022545106A (fr)
KR (1) KR20220066276A (fr)
CN (1) CN114599389A (fr)
AU (1) AU2020333967A1 (fr)
CA (1) CA3152009A1 (fr)
MX (1) MX2022002171A (fr)
WO (1) WO2021035177A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020340881A1 (en) 2020-04-02 2021-10-21 Regeneron Pharmaceuticals, Inc. Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
CN116057069A (zh) 2020-06-03 2023-05-02 瑞泽恩制药公司 用抗SARS-CoV-2刺突糖蛋白抗体治疗或预防SARS-CoV-2感染和COVID-19的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101802197A (zh) * 2007-05-14 2010-08-11 比奥根艾迪克Ma公司 单链FC(ScFc)区、包含其的结合多肽及与其相关的方法
WO2011103584A2 (fr) * 2010-02-19 2011-08-25 Xencor, Inc. Nouvelles immunoadhésines ctla4-1g
SG194099A1 (en) * 2011-04-15 2013-11-29 Compugen Ltd Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
TW201817745A (zh) * 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之FcRn結合域的治療性抗原結合分子
WO2018128826A1 (fr) * 2017-01-06 2018-07-12 Cidara Therapeutics, Inc. Compositions et méthodes de traitement d'infections bactériennes
US20200148779A1 (en) * 2017-05-25 2020-05-14 Bristol-Myers Squibb Company MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH
EP3665195A4 (fr) * 2017-08-11 2021-05-19 Research Development Foundation Variants d'anticorps fc modifiés pour demi-vie sérique améliorée
JP2021506291A (ja) * 2017-12-19 2021-02-22 ゼンコア インコーポレイテッド 改変されたil−2 fc融合タンパク質
US20230079107A1 (en) * 2019-06-13 2023-03-16 Cidara Therapeutics, Inc. Compositions and methods for the treatment of human immunodeficiency virus

Similar Documents

Publication Publication Date Title
JP7523897B2 (ja) 呼吸器合胞体ウイルス(rsv)ワクチン
JP7556848B2 (ja) mRNA治療薬を使用したがんを治療するための方法及び組成物
JP7150608B6 (ja) 多量体コード核酸及びその使用
JP2023103250A (ja) 活性化がん遺伝子変異ペプチドをコードする免疫調節治療mRNA組成物
TWI528963B (zh) 治療或預防眼科疾病的方法
JP7418419B2 (ja) 核酸送達のための第三級アミノ脂質化カチオン性ペプチド
JP7170820B2 (ja) 修飾オリゴヌクレオチド及び使用方法
JP2023109824A (ja) GalNAc誘導体
JP7269968B2 (ja) ペプチド担体上の多重オリゴヌクレオチド部分
JP2017506521A5 (fr)
CA3003399A1 (fr) Polypeptides conditionnellement actifs
JP2013540770A5 (fr)
EP2438079A2 (fr) Compositions pour l'administration d'acides nucléiques et procédés pour les utiliser
CN113785054A (zh) 包含艾杜糖醛酸2-硫酸酯酶的蛋白质分子制剂
JP2022126804A5 (fr)
CN107708416A (zh) 肽组合物和使用方法
JP2024040213A (ja) 高濃縮アルファ-1プロテイナーゼインヒビターを含む組成物及びそれを得るための方法
CN118159278A (zh) 单链可变片段(scFv)修饰的脂质纳米颗粒组合物及其用途
JPWO2021035177A5 (fr)
JP2020507350A5 (fr)
JP2001515060A (ja) 新リポポリアミン、その調製および適用
AU2021314336A1 (en) Compositions and methods for treating viral infections
JPWO2020092019A5 (fr)
JP2023516392A (ja) アプタマーおよびその使用
JP2017538681A5 (fr)